News

Study surveys recent orphan-drug approvals, finding good alignment between Orphan Drug Act goals and achievements

Results of a survey panel by QPharma, presented at PDMA Sharing Conference, show a wide spread of reactions and concerns over agg-spend rules

Radiopharmaceuticals critical to diagnostic imaging will become more available from a Zevacor facility

Exhibition brings out the latest in temperature-controlled shipping

Canadian Blood Service works with manufacturers and nonprofits to expand Factor VIII supplies to the developing world

Mark Walchirk of McKesson joins executive board

New service launched by WEGO Health offers rapid feedback from key opinion influencers in consumer healthcare

Bill includes voluntary oversight by FDA of outsourced compounded pharmaceuticals, national distributor licensure, and a timetable for serialization and drug tracking

Regulation of compounding pharmacies will be included in the new Drug Quality and Security Act

Cells, tissues and regenerative-medicine materials, in biobanking or clinical research, are the focus

Feasibility study with US Oncology Research will evaluate the practicality of multiple biomarker testing

UDIs will be in place starting in late 2014, and rolling out over the next four years thereafter

The perfect pharmaceutical product would be a pill or injection that, once taken, has a near-immediate beneficial effect.

For specialty pharmaceuticals, the connection between manufacturer, payer and patient is the rising crop of hub services

Regulatory compliance remains the top concern globally, but security and spoilage are high in the Asia/Pacific region

Abbott Labs is tops in healthcare equipment

CRM-software training company expands its international presence

The Biofeedback services closes the loop on patient outcomes

Sept. 23 is the deadline for implementing new restrictions on sending industry-sponsored refill reminders to patient

Rising costs of cancer care, and a lack of tools to manage quality of care, are highlighted in new Institute of Medicine report

DrugChannels.net draws out specialty pharmacies from the annual list; only some work directly with manufacturers

But their evidence seems to validates industry's claim that coupons are not generics killers

DoD experienced a 16.7% reduction in prescribing costs versus retail pharmacies

Simplist line of generic injectables now includes ondansetron, an antiemetic currently in short supply

Medical device packaging slated for a 5.9% annual rise through that period

State-by-state, plan-by-plan analysis from CVS Caremark highlights multibillion-dollar savings if adherence rates are improved

Essential for approving some new products, biomarkers are becoming integrated with patient therapies